Log In
BCIQ
Print this Print this
 

Nano-PGE1 (LT-0101)

  Manage Alerts
Collapse Summary General Information
Company LTT Bio-Pharma Co. Ltd.
DescriptionThird generation nanoparticle formulation of PGE1
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today